Gambia lawmakers say India's Maiden Pharmaceuticals to blame for child kidney injury deaths

Gambia's parliamentary select committee on health on Tuesday said the India-based Maiden Pharmaceuticals Ltd was responsible for the deaths of over 70 children from acute kidney injury and called on the government for legal action against the company.

A few days ago, India's Central Drug Laboratory (CDL) which carried out tests on the samples from the Sonepat-based company, found the products to be complying with norms, putting the onus on WHO for "prematurely" blaming the company for the deaths without any "independent verification".

Country's drug controller General of India (DCGI) has written a strongly worded letter to Rogerio Gaspar, Director, Regulation and Prequalification, WHO informing that all control samples of the products have been found to be complying with specifications.